STOCK TITAN

Ironwood Pharmaceuticals, Inc. (IRWD) Net Income by Year

IRWD

Ironwood Pharmaceuticals, Inc. reported $24.0M in net income in fiscal year 2025. This represents an increase of 2629.2% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $129.9M in net income. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Ironwood Pharmaceuticals, Inc. has filed alongside them.

FY2025 annual
Net Income $24.0M
YoY +2629.2%
5Y CAGR -25.7%
10Y CAGR n/m
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

IRWD Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Net Income$129.9M$24.0M+2629.2%$880Kn/m-$1.0B-672.5%$175.1M-66.9%$528.4M+397.7%$106.2M+393.7%$21.5Mn/m-$282.4Mn/m-$116.9Mn/m-$81.7Mn/m-$142.7Mn/m-$189.6Mn/m-$272.8Mn/m-$72.6Mn/m-$64.9M

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

IRWD Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-KQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-KQ2'2410-KQ1'2410-KQ4'2310-KQ3'2310-K
Net Income$51.3M+117.3%$40.8Mn/m-$2.3M-200.9%$40.1M+999.3%$23.6Mn/m-$37.4Mn/m$2.3Mn/m$3.6M-76.2%-$860Kn/m-$4.2M-109.1%-$1.1M-102.2%$15.3M-69.6%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Ironwood Pharmaceuticals, Inc. financials

Frequently Asked Questions

What was Ironwood Pharmaceuticals, Inc.'s net income in fiscal year 2025?

Ironwood Pharmaceuticals, Inc. reported $24.0M in net income in fiscal year 2025.

How fast is Ironwood Pharmaceuticals, Inc.'s net income growing?

Ironwood Pharmaceuticals, Inc. (IRWD) net income rose by 2629.2% year over year, from $880K to $24.0M in fiscal year 2025.

What is Ironwood Pharmaceuticals, Inc.'s net income over the last twelve months?

Ironwood Pharmaceuticals, Inc. (IRWD) reported $129.9M in net income over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Across the 15 fiscal years this page covers, Ironwood Pharmaceuticals, Inc. (IRWD) net income went from -$64.9M in fiscal year 2011 to $24.0M in fiscal year 2025.

Ironwood Pharmaceuticals, Inc. (IRWD) reported $51.3M in net income in Q2 2026. This represents an increase of 117.3% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Ironwood Pharmaceuticals, Inc. (IRWD) reported on that line in every period on record.